Information  X 
Enter a valid email address

AstraZeneca PLC (AZN)

  Print      Mail a friend       Annual reports

Thursday 24 April, 2014

AstraZeneca PLC

Result of AGM

RNS Number : 4823F
AstraZeneca PLC
24 April 2014
 



ASTRAZENECA PLC - ANNUAL GENERAL MEETING 2014

 

Results of Annual General Meeting held on 24 April 2014

 

AstraZeneca PLC announced the results of the voting at its Annual General Meeting today.  As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 1 - 9 and 13 were passed as ordinary resolutions and resolutions 10 - 12 were passed as special resolutions.

 

 


RESOLUTION

VOTES FOR

% OF VOTES CAST

VOTES AGAINST

% OF VOTES CAST

VOTES CAST IN TOTAL

TOTAL VOTES CAST AS A % OF ISSUED SHARE CAPITAL

VOTES WITHHELD

1

To receive the Company's Accounts and the Reports of the Directors and Auditor for the year ended 31 December 2013

 

870,033,204

97.89

18,778,918

2.11

888,812,122

70.46%

11,139,925

2

To confirm dividends

 

893,931,728

99.57

3,902,685

0.43

897,834,413

71.17%

2,117,634

3

To appoint KPMG LLP, London as Auditor

 

876,625,428

98.63

12,214,852

1.37

888,840,280

70.46%

11,111,767

4

To authorise the Directors to agree the remuneration of the Auditor

 

893,579,679

99.54

4,118,441

0.46

897,698,120

71.16%

2,253,927

5a

To re-elect Leif Johansson as a Director

 

889,965,734

99.14

7,676,973

0.86

897,642,707

71.16%

2,309,340

5b

To re-elect Pascal Soriot as a Director

 

897,134,446

99.96

371,409

0.04

897,505,855

71.15%

2,446,192

5c

To elect Marc Dunoyer as a Director

 

889,628,471

99.12

7,871,986

0.88

897,500,457

71.15%

2,451,590

5d

To re-elect Geneviève Berger as a Director

 

896,973,595

99.94

537,923

0.06

897,511,518

71.15%

2,440,529

5e

To re-elect Bruce Burlington as a Director

 

897,004,578

99.95

479,515

0.05

897,484,093

71.15%

2,467,954

5f

To elect Ann Cairns as a Director.

 

897,096,680

99.95

434,031

0.05

897,530,711

71.15%

2,421,336

5g

To re-elect Graham Chipchase as a Director

 

895,582,520

99.79

1,906,668

0.21

897,489,188

71.15%

2,462,859

5h

To re-elect Jean-Philippe Courtois as a Director

 

507,689,816

56.97

383,431,429

43.03

891,121,245

70.64%

8,830,801

5i

To re-elect Rudy Markham as a Director

 

883,555,362

98.45

13,948,771

1.55

897,504,133

71.15%

2,447,914

5j

To re-elect Nancy Rothwell as a Director

 

866,230,058

96.51

31,324,104

3.49

897,554,162

71.15%

2,397,885

5k

To re-elect Shriti Vadera as a Director

 

890,107,349

99.17

7,412,193

0.83

897,519,542

71.15%

2,432,505

5l

To re-elect John Varley as a Director.

 

865,725,412

96.46

31,781,043

3.54

897,506,455

71.15%

2,445,592

5m

To re-elect Marcus Wallenberg as a Director.

 

794,350,592

89.19

96,276,858

10.81

890,627,450

70.60%

9,324,597

6

To approve the Annual Report on Remuneration for the year ended 31 December 2013

546,233,371

61.46

342,504,005

38.54

888,737,376

70.45%

11,214,670

7

To approve the Directors' Remuneration Policy

 

623,298,717

85.00

110,030,311

15.00

733,329,028

58.13%

166,623,018

8

To authorise limited EU political donations

 

869,296,180

97.48

22,506,342

2.52

891,802,522

70.70%

8,149,525

9

To authorise the Directors to allot shares

 

802,973,415

89.68

92,408,410

10.32

895,381,825

70.98%

4,391,643

10

To authorise the Directors to disapply pre-emption rights

 

880,119,551

98.50

13,443,551

1.50

893,563,102

70.84%

6,388,945

11

To authorise the Company to purchase its own shares

 

896,314,664

99.85

1,320,394

0.15

897,635,058

71.16%

2,316,989

12

To reduce the notice period for general meetings

753,622,756

83.98

143,754,313

16.02

897,377,069

71.14%

2,574,978

13

To approve the AstraZeneca 2014 Performance Share Plan

 

835,615,520

93.66

56,608,840

6.34

892,224,360

70.73%

7,727,687

 

 

 

Issued capital

As at 22 April 2014, the number of issued shares of the Company was 1,261,461,150 ordinary shares, which was the total number of shares entitling the holders to attend and vote for or against all the resolutions at the AGM. In accordance with the Company's Articles of Association, on a poll every member present in person or by proxy has one vote for every share held.

 

 

A C N Kemp

Company Secretary

24 April 2014


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGPGURUCUPCGQC

a d v e r t i s e m e n t